Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI-Powered health coach in your pocket: could this app prevent disease?

NCT ID NCT07612852

Prevention Sponsor: Istituto per la Ricerca e l'Innovazione Biomedica Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a digital platform called DELPHI that uses a wearable fitness tracker and smartphone app to give personalized lifestyle tips on exercise, sleep, diet, and stress. Researchers will enroll 200 healthy adults in southern Italy and randomly assign them to use either the full platform with AI recommendations or a basic version that only tracks data. The goal is to see if the platform is easy to use and acceptable, and whether it might help improve quality of life and reduce risk factors for chronic diseases.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
DELPHI Personalized Digital Prevention Platform (digital platform with wearable sensors and AI recommendations)
What this could lead to
If successful, this could provide a scalable, personalized digital tool to help healthy adults adopt and maintain healthier lifestyles, potentially reducing the risk of chronic diseases.
What could go wrong
This is an early pilot study with only 200 participants, focused on feasibility and usability, not on proving health outcomes. The results may not generalize to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Apparent good general health status, confirmed by medical history and initial self-assessment. * Ability to understand the study information and provide informed consent. * Availability and motivation to participate for the entire duration of the study (12 months). * Access to a smartphone compatible with the DELPHI application. * Willingness to wear the wearable devices for continuous monitoring of physiological parameters. * Basic familiarity with mobile applications or willingness to receive training on their use. * Signed informed consent. Exclusion Criteria: * Presence of severe chronic diseases in active phase (e.g., oncological, cardiovascular, or neurological diseases). * Acute or unstable conditions that could compromise participation in the protocol. * Current pregnancy. * Diagnosed major cognitive or psychiatric disorders that hinder understanding of or adherence to the protocol. * Current use of medications that significantly affect the parameters being monitored (e.g., psychotropic drugs, beta-blockers). * Simultaneous participation in other clinical studies. * Logistical difficulties that prevent frequent interaction with the platform (e.g., lack of connection, unwillingness to attend periodic follow-ups).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health promotion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Risk Reduction Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health promotion Life style, healthy Risk reduction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institute for Biomedical Research and Innovation (IRIB)-National Reasearch Council (CNR)

    RECRUITING

    Messina, 98164, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.